Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 6, 2021 · 10-Q · 36 days after period end · 0001213900-21-024773
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$13.47M | -$10.06M | -$6.53M | -$6.08M |
| EPS Diluted | -$1.20 | -$1.81 | -$0.58 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end
